Oseltamivir is the active ingredient in the medication.It is a neuraminidase inhibitor.
Treatment of uncomplicated influenza A and B infections in adults and children aged 1 year and older.
Prevention of influenza A and B infections in individuals at high risk of complications.
Fluhalt 75mg Cap (Oseltamivir) works by blocking the activity of neuraminidase, an enzyme produced by the influenza virus. This enzyme helps the virus spread within the body. By inhibiting neuraminidase, oseltamivir prevents the virus from replicating and spreading, reducing the severity and duration of influenza symptoms.
Store oseltamivir at room temperature, between 15°C and 30°C (59°F and 86°F), in a dry place.
The dosage and duration of treatment vary depending on the patient's age, weight, and condition.
Oseltamivir is typically taken orally, twice a day, with or without food.
It is important to follow the instructions provided by your healthcare professional.
Nausea
Vomiting
Diarrhea
Headache
Dizziness
Cough
Sore throat
Runny nose
Fatigue
Muscle aches
Allergic reactions, including rash, itching, and swelling.
Alcohol consumption may increase the risk of side effects. It is best to avoid alcohol while taking oseltamivir.
Oseltamivir may cause dizziness or drowsiness. Avoid driving or operating machinery until you know how this medication affects you.
Oseltamivir should be used during pregnancy only if the potential benefit outweighs the risk to the fetus. It is not known if oseltamivir passes into breast milk. Consult your healthcare professional before using oseltamivir if you are pregnant or breastfeeding.
Oseltamivir is safe and effective for children aged 1 year and older. However, the dosage may vary depending on the child's age and weight.
Oseltamivir is primarily eliminated through the kidneys. If you have kidney disease, your healthcare professional may need to adjust your dosage.
Oseltamivir is metabolized by the liver. If you have liver disease, your healthcare professional may need to monitor you closely for side effects.
https://www.cdc.gov/flu/professionals/antivirals/oseltamivir.htm
https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-recommends-avoiding-tamiflu-oseltamivir-children-with-neurological-conditions-and-caution-patients-with-certain-conditions-including-gastrointestinal-conditions-and-renal-disease
https://www.webmd.com/drugs/2/drug-10634/oseltamivir-oral/details
